Insider Shareholders with Direct Ownership of Lexicon Pharmaceuticals, Inc. (LXRX)
This section provides a comprehensive overview of the insiders with direct ownership of Lexicon Pharmaceuticals, Inc. (LXRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
LEXICON PHARMACEUTICALS, INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Raymond Debbane
Director |
1,031,996 | 0 | 1,348,879 $2.63 Million | 7 |
Apr 28, 2024
Added 0.59%
|
|
Lonnel Coats
Chief Executive Officer |
1,014,635 | 215,433 | 1,098,068 $2.14 Million | 14 |
Feb 28, 2024
Reduced 5.29%
|
|
Jeffrey L Wade
President and COO |
333,522 | 120,303 | 324,214 $632,217 | 10 |
Feb 28, 2024
Reduced 10.41%
|
|
Alan J Main
EVP, Innov & Chem Sciences |
236,607 | 85,523 | 255,724 $498,661 | 8 |
Feb 28, 2024
Reduced 8.71%
|
|
Philippe Amouyal
Director |
31,996 | 0 | 248,364 $484,309 | 4 |
Apr 28, 2024
Added 3.13%
|
|
Brian T Crum
SVP, General Counsel & Secr. |
203,825 | 76,060 | 177,497 $346,119 | 8 |
Feb 28, 2024
Reduced 12.61%
|
|
Christopher J Sobecki
Director |
31,996 | 0 | 167,055 $325,757 | 4 |
Apr 28, 2024
Added 4.59%
|
|
Kenneth B. Kassler Taub
SVP, Regulatory & QA |
156,914 | 56,712 | 162,672 $317,210 | 6 |
Feb 28, 2024
Reduced 13.02%
|
|
Praveen Tyle
EVP, R&D |
68,007 | 16,560 | 120,791 $235,542 | 2 |
Feb 28, 2021
Reduced 12.06%
|
|
Sam L Barker
Director |
31,996 | 0 | 87,649 $170,915 | 4 |
Apr 28, 2024
Added 8.39%
|
|
James F Tessmer
VP, Finance & Accounting |
40,316 | 33,677 | 71,766 $139,943 | 4 |
Mar 15, 2021
Reduced 14.33%
|
|
Kiernan Seth
VP, Chief Commercial Officer |
73,210 | 20,074 | 53,136 $103,615 | 4 |
Feb 28, 2023
Reduced 18.19%
|
|
Wendy Mc Dermott
VP, Human Resources |
81,584 | 28,890 | 52,694 $102,753 | 6 |
Feb 28, 2024
Reduced 29.85%
|
|
Judith L Swain
Director |
31,996 | 0 | 48,364 $94,309 | 4 |
Apr 28, 2024
Added 14.24%
|
|
Robert J Md Lefkowitz
Director |
31,996 | 0 | 48,364 $94,309 | 4 |
Apr 28, 2024
Added 14.24%
|
|
Kristen Alexander
VP, Finance and Accounting |
59,260 | 20,460 | 47,800 $93,210 | 6 |
Feb 28, 2024
Reduced 19.79%
|
|
Craig B Granowitz
SVP, Chief Medical Officer |
91,623 | 43,997 | 47,626 $92,870 | 4 |
Feb 28, 2024
Reduced 39.63%
|
|
Alan S Nies
Director |
23,964 | 0 | 41,046 $80,039 | 3 |
May 21, 2023
Added 18.48%
|
|
Frank Palantoni
Director |
23,964 | 0 | 40,332 $78,647 | 3 |
May 21, 2023
Added 18.74%
|
|
C.V. Invus
Director |
0 | 4,321,214 | 0 $0 | 1 |
Dec 31, 2020
Reduced 100.0%
|